Development
Ultralife Corporation
ULBI
$7.70
-$0.155-1.98%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 1.33M | 3.34M | -346.00K | -224.00K | -239.00K |
| Total Depreciation and Amortization | 987.00K | 987.00K | 971.00K | 1.04M | 1.13M |
| Total Amortization of Deferred Charges | 16.00K | 16.00K | 16.00K | 11.00K | 8.00K |
| Total Other Non-Cash Items | 461.00K | 1.44M | -240.00K | -56.00K | -132.00K |
| Change in Net Operating Assets | -3.68M | -4.03M | -1.77M | 1.79M | -1.20M |
| Cash from Operations | -889.00K | 1.75M | -1.37M | 2.56M | -427.00K |
| Capital Expenditure | -534.00K | -516.00K | -497.00K | -283.00K | -811.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -534.00K | -516.00K | -497.00K | -283.00K | -811.00K |
| Total Debt Issued | 1.95M | 2.00M | 2.30M | 0.00 | 1.80M |
| Total Debt Repaid | -500.00K | -500.00K | -500.00K | -1.50M | -500.00K |
| Issuance of Common Stock | 979.00K | 62.00K | -- | 0.00 | 3.00K |
| Repurchase of Common Stock | -- | -- | -- | -4.00K | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -75.00K | 0.00 |
| Cash from Financing | 2.43M | 1.56M | 1.80M | -1.58M | 1.30M |
| Foreign Exchange rate Adjustments | 12.00K | -119.00K | -46.00K | -40.00K | -128.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.02M | 2.68M | -108.00K | 662.00K | -63.00K |